subcutaneous produces reliable systemic absorption Requires greater technique and carries a marginally higher risk of injection site reaction Who injection is best suited for: Tendon, ligament, or muscle injuries Post-surgical tissue recovery Bone healing support Systemic anti-inflammatory goals Any indication where the target tissue is not the GI tract Practical considerations: Requires comfort with self-injection or clinical administration Sterile preparation is non-negotiable contaminated peptide solutions carry real infection risk Quality of the compound matters enormously
However, GIP receptor antagonism has not, so far, resulted in higher or lower circulating levels of GIP (46, 75, 87)
However, research shows that lean mass loss can be significantly mitigated through resistance training and adequate protein intake during GLP-1 therapy
Primer sequences are listed in Table 1, with LsActin used as the reference gene for normalization 57,58
Alpha-Lipoic Acid: Boosts antioxidant power